2017
Hormone Receptor-Positive Breast Cancer Has a Worse Prognosis in Male Than in Female Patients
Li X, Yang J, Krishnamurti U, Huo L, Ward K, O'Regan R, Peng L. Hormone Receptor-Positive Breast Cancer Has a Worse Prognosis in Male Than in Female Patients. Clinical Breast Cancer 2017, 17: 356-366. PMID: 28576631, DOI: 10.1016/j.clbc.2017.03.005.Peer-Reviewed Original ResearchConceptsMale breast carcinomaFemale breast carcinomaHormone receptorsMBC patientsWorse OSOverall survivalBreast carcinomaBreast cancerStage IHormone receptor-positive breast cancerEarly-stage hormone receptorReceptor-positive breast cancerNational Cancer Institute's SurveillanceEnd Results (SEER) databaseWorse overall survivalBreast carcinoma casesSimilar survival ratesMBC subtypesWorse survivalClinicopathologic featuresOverall incidenceResults databaseWorse prognosisHER2 statusFBC patients
1997
Time trend of female breast carcinoma In Situ by race and histology in Connecticut, U.S.A.
Zheng T, Holford T, Chen Y, Jones B, Flannery J, Boyle P. Time trend of female breast carcinoma In Situ by race and histology in Connecticut, U.S.A. European Journal Of Cancer 1997, 33: 96-100. PMID: 9071907, DOI: 10.1016/s0959-8049(96)00371-1.Peer-Reviewed Original ResearchConceptsAge-adjusted incidence ratesSitu breast cancerFemale breast carcinomaIncidence rateBreast cancerMammography screeningBreast carcinomaOverall age-adjusted incidence rateAge group 40 yearsAge groupsEarly-stage breast cancerAge-specific incidence ratesFemale breast cancer incidenceConnecticut Tumor RegistryBreast cancer incidenceStage breast cancerEfficacy of mammographyFemale breast cancerAge group 40Older age groupsTime trendsTumor RegistryIncident casesDuctal carcinomaCancer incidence
1995
DNA Ploidy as a Significant Predictor of Recurrence‐Free Survival in Male Patients with Breast Cancer
Mani S, Haffty B, Sinard J, Fischer D, Papac R, Flynn S. DNA Ploidy as a Significant Predictor of Recurrence‐Free Survival in Male Patients with Breast Cancer. The Breast Journal 1995, 1: 356-361. DOI: 10.1111/j.1524-4741.1995.tb00262.x.Peer-Reviewed Original ResearchMale breast carcinomaDisease-free survivalRecurrence-free survivalBreast carcinomaDNA ploidyDNA flow cytometryNodal statusPrognostic significanceTumor sizeBreast cancerLocal recurrence-free survivalDistant metastasis-free survivalFlow cytometrySignificant prognostic factorsMale breast cancerMetastasis-free survivalSignificant prognostic indicatorFemale breast carcinomaParaffin-embedded blocksDNA flow cytometry analysisFlow cytometry analysisLocal recurrenceOverall survivalPrognostic factorsDistant metastasis
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply